Literature DB >> 24022137

Amgen best-seller challenged by generics.

Mark Ratner.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 24022137     DOI: 10.1038/nbt0913-774b

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  The gatekeepers of effectiveness.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2012-06-07       Impact factor: 54.908

2.  Therapies for active rheumatoid arthritis after methotrexate failure.

Authors:  James R O'Dell; Ted R Mikuls; Thomas H Taylor; Vandana Ahluwalia; Mary Brophy; Stuart R Warren; Robert A Lew; Amy C Cannella; Gary Kunkel; Ciaran S Phibbs; Aslam H Anis; Sarah Leatherman; Edward Keystone
Journal:  N Engl J Med       Date:  2013-06-11       Impact factor: 91.245

  2 in total
  1 in total

1.  Biosimilars or semi-similars?

Authors:  Huub Schellekens; Ellen Moors
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.